| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |